nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Gemcitabine—pancreatic cancer	0.332	1	CiPCiCtD
Fluorouracil—colon cancer—pancreatic cancer	0.126	0.552	CtDrD
Fluorouracil—stomach cancer—pancreatic cancer	0.102	0.448	CtDrD
Fluorouracil—SLC29A1—pancreatic cancer	0.08	0.362	CbGaD
Fluorouracil—TYMP—pancreatic cancer	0.0606	0.275	CbGaD
Fluorouracil—DPYD—pancreatic cancer	0.0516	0.234	CbGaD
Fluorouracil—TYMS—pancreatic cancer	0.0285	0.129	CbGaD
Fluorouracil—SLC29A1—Gemcitabine—pancreatic cancer	0.0283	0.212	CbGbCtD
Fluorouracil—TYMS—Gemcitabine—pancreatic cancer	0.0262	0.197	CbGbCtD
Fluorouracil—CYP2A6—Tamoxifen—pancreatic cancer	0.007	0.0526	CbGbCtD
Fluorouracil—SLC22A7—Docetaxel—pancreatic cancer	0.00693	0.0521	CbGbCtD
Fluorouracil—ABCC4—Sunitinib—pancreatic cancer	0.00674	0.0507	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—pancreatic cancer	0.00661	0.0497	CbGbCtD
Fluorouracil—ABCG2—Tamoxifen—pancreatic cancer	0.00647	0.0487	CbGbCtD
Fluorouracil—ABCG2—Erlotinib—pancreatic cancer	0.00551	0.0414	CbGbCtD
Fluorouracil—ABCG2—Irinotecan—pancreatic cancer	0.00497	0.0374	CbGbCtD
Fluorouracil—ALB—Erlotinib—pancreatic cancer	0.0038	0.0285	CbGbCtD
Fluorouracil—ABCG2—Docetaxel—pancreatic cancer	0.00364	0.0274	CbGbCtD
Fluorouracil—ABCG2—Sunitinib—pancreatic cancer	0.00363	0.0273	CbGbCtD
Fluorouracil—CYP2C8—Tamoxifen—pancreatic cancer	0.00345	0.0259	CbGbCtD
Fluorouracil—ALB—Irinotecan—pancreatic cancer	0.00343	0.0258	CbGbCtD
Fluorouracil—CYP1A2—Dacarbazine—pancreatic cancer	0.00336	0.0252	CbGbCtD
Fluorouracil—CYP2C8—Erlotinib—pancreatic cancer	0.00293	0.022	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—pancreatic cancer	0.00272	0.0204	CbGbCtD
Fluorouracil—CYP1A2—Tamoxifen—pancreatic cancer	0.00267	0.0201	CbGbCtD
Fluorouracil—CYP2C9—Tamoxifen—pancreatic cancer	0.00241	0.0181	CbGbCtD
Fluorouracil—CYP1A2—Erlotinib—pancreatic cancer	0.00227	0.0171	CbGbCtD
Fluorouracil—ABCC3—bile duct—pancreatic cancer	0.00187	0.208	CbGeAlD
Fluorouracil—UMPS—islet of Langerhans—pancreatic cancer	0.00086	0.0959	CbGeAlD
Fluorouracil—UPP1—islet of Langerhans—pancreatic cancer	0.000788	0.088	CbGeAlD
Fluorouracil—UMPS—pancreas—pancreatic cancer	0.000604	0.0674	CbGeAlD
Fluorouracil—UPP1—pancreas—pancreatic cancer	0.000554	0.0618	CbGeAlD
Fluorouracil—UMPS—digestive system—pancreatic cancer	0.000516	0.0576	CbGeAlD
Fluorouracil—UPP1—digestive system—pancreatic cancer	0.000473	0.0528	CbGeAlD
Fluorouracil—DPYD—pancreas—pancreatic cancer	0.00045	0.0502	CbGeAlD
Fluorouracil—ABCC3—gall bladder—pancreatic cancer	0.000398	0.0444	CbGeAlD
Fluorouracil—ALB—gall bladder—pancreatic cancer	0.000339	0.0379	CbGeAlD
Fluorouracil—SLC29A1—islet of Langerhans—pancreatic cancer	0.000285	0.0318	CbGeAlD
Fluorouracil—TYMP—digestive system—pancreatic cancer	0.000223	0.0248	CbGeAlD
Fluorouracil—SLC22A7—digestive system—pancreatic cancer	0.000222	0.0248	CbGeAlD
Fluorouracil—MTHFR—digestive system—pancreatic cancer	0.000209	0.0234	CbGeAlD
Fluorouracil—SLC29A1—pancreas—pancreatic cancer	0.000201	0.0224	CbGeAlD
Fluorouracil—TYMS—digestive system—pancreatic cancer	0.000191	0.0213	CbGeAlD
Fluorouracil—SLC29A1—digestive system—pancreatic cancer	0.000171	0.0191	CbGeAlD
Fluorouracil—ABCC3—digestive system—pancreatic cancer	0.000157	0.0175	CbGeAlD
Fluorouracil—ABCC4—pancreas—pancreatic cancer	0.000151	0.0169	CbGeAlD
Fluorouracil—ABCC4—digestive system—pancreatic cancer	0.000129	0.0144	CbGeAlD
Fluorouracil—UMPS—Idarubicin—Epirubicin—pancreatic cancer	0.000126	0.135	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—pancreatic cancer	0.000126	0.135	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—pancreatic cancer	0.000126	0.135	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—pancreatic cancer	0.000117	0.124	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—pancreatic cancer	0.000117	0.124	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—pancreatic cancer	0.000117	0.124	CbGdCrCtD
Fluorouracil—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	9.43e-05	0.1	CbGdCrCtD
Fluorouracil—TYMS—Gefitinib—Erlotinib—pancreatic cancer	9.04e-05	0.0964	CbGdCrCtD
Fluorouracil—CYP1A2—digestive system—pancreatic cancer	8.78e-05	0.0098	CbGeAlD
Fluorouracil—CYP2C9—digestive system—pancreatic cancer	8.34e-05	0.00931	CbGeAlD
Fluorouracil—Rhinitis—Docetaxel—pancreatic cancer	3.3e-05	0.000883	CcSEcCtD
Fluorouracil—Anaphylactic shock—Gemcitabine—pancreatic cancer	3.3e-05	0.000882	CcSEcCtD
Fluorouracil—Oedema—Gemcitabine—pancreatic cancer	3.3e-05	0.000882	CcSEcCtD
Fluorouracil—Haemorrhage—Docetaxel—pancreatic cancer	3.29e-05	0.000881	CcSEcCtD
Fluorouracil—Cardiac failure—Epirubicin—pancreatic cancer	3.29e-05	0.00088	CcSEcCtD
Fluorouracil—Diarrhoea—Tamoxifen—pancreatic cancer	3.28e-05	0.000878	CcSEcCtD
Fluorouracil—Hypoaesthesia—Docetaxel—pancreatic cancer	3.28e-05	0.000877	CcSEcCtD
Fluorouracil—Lethargy—Epirubicin—pancreatic cancer	3.28e-05	0.000877	CcSEcCtD
Fluorouracil—Infection—Gemcitabine—pancreatic cancer	3.27e-05	0.000876	CcSEcCtD
Fluorouracil—Pharyngitis—Docetaxel—pancreatic cancer	3.27e-05	0.000874	CcSEcCtD
Fluorouracil—Body temperature increased—Sunitinib—pancreatic cancer	3.25e-05	0.000869	CcSEcCtD
Fluorouracil—Diarrhoea—Erlotinib—pancreatic cancer	3.25e-05	0.000869	CcSEcCtD
Fluorouracil—Nervous system disorder—Gemcitabine—pancreatic cancer	3.23e-05	0.000865	CcSEcCtD
Fluorouracil—Thrombocytopenia—Gemcitabine—pancreatic cancer	3.23e-05	0.000864	CcSEcCtD
Fluorouracil—Anorexia—Irinotecan—pancreatic cancer	3.23e-05	0.000863	CcSEcCtD
Fluorouracil—Osteoarthritis—Epirubicin—pancreatic cancer	3.21e-05	0.000859	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	3.21e-05	0.000859	CcSEcCtD
Fluorouracil—Dizziness—Tamoxifen—pancreatic cancer	3.17e-05	0.000849	CcSEcCtD
Fluorouracil—Hypotension—Irinotecan—pancreatic cancer	3.16e-05	0.000846	CcSEcCtD
Fluorouracil—Anorexia—Gemcitabine—pancreatic cancer	3.14e-05	0.000841	CcSEcCtD
Fluorouracil—Dizziness—Erlotinib—pancreatic cancer	3.14e-05	0.00084	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—pancreatic cancer	3.11e-05	0.000832	CcSEcCtD
Fluorouracil—Hypotension—Gemcitabine—pancreatic cancer	3.08e-05	0.000824	CcSEcCtD
Fluorouracil—Insomnia—Irinotecan—pancreatic cancer	3.06e-05	0.000819	CcSEcCtD
Fluorouracil—Cardiac arrest—Epirubicin—pancreatic cancer	3.05e-05	0.000817	CcSEcCtD
Fluorouracil—Vomiting—Tamoxifen—pancreatic cancer	3.05e-05	0.000816	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—pancreatic cancer	3.04e-05	0.000814	CcSEcCtD
Fluorouracil—Paraesthesia—Irinotecan—pancreatic cancer	3.04e-05	0.000813	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—pancreatic cancer	3.03e-05	0.000811	CcSEcCtD
Fluorouracil—Hypersensitivity—Sunitinib—pancreatic cancer	3.03e-05	0.00081	CcSEcCtD
Fluorouracil—Rash—Tamoxifen—pancreatic cancer	3.02e-05	0.000809	CcSEcCtD
Fluorouracil—Dermatitis—Tamoxifen—pancreatic cancer	3.02e-05	0.000809	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—pancreatic cancer	3.02e-05	0.000808	CcSEcCtD
Fluorouracil—Vomiting—Erlotinib—pancreatic cancer	3.02e-05	0.000807	CcSEcCtD
Fluorouracil—Dyspnoea—Irinotecan—pancreatic cancer	3.02e-05	0.000807	CcSEcCtD
Fluorouracil—Somnolence—Irinotecan—pancreatic cancer	3.01e-05	0.000805	CcSEcCtD
Fluorouracil—Headache—Tamoxifen—pancreatic cancer	3e-05	0.000804	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	3e-05	0.000804	CcSEcCtD
Fluorouracil—Rash—Erlotinib—pancreatic cancer	2.99e-05	0.000801	CcSEcCtD
Fluorouracil—Dermatitis—Erlotinib—pancreatic cancer	2.99e-05	0.0008	CcSEcCtD
Fluorouracil—Insomnia—Gemcitabine—pancreatic cancer	2.98e-05	0.000798	CcSEcCtD
Fluorouracil—Dyspepsia—Irinotecan—pancreatic cancer	2.98e-05	0.000797	CcSEcCtD
Fluorouracil—Headache—Erlotinib—pancreatic cancer	2.97e-05	0.000796	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—pancreatic cancer	2.97e-05	0.000795	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	2.97e-05	0.000795	CcSEcCtD
Fluorouracil—Paraesthesia—Gemcitabine—pancreatic cancer	2.96e-05	0.000792	CcSEcCtD
Fluorouracil—Dry skin—Epirubicin—pancreatic cancer	2.94e-05	0.000787	CcSEcCtD
Fluorouracil—Decreased appetite—Irinotecan—pancreatic cancer	2.94e-05	0.000787	CcSEcCtD
Fluorouracil—Arrhythmia—Docetaxel—pancreatic cancer	2.94e-05	0.000787	CcSEcCtD
Fluorouracil—Dyspnoea—Gemcitabine—pancreatic cancer	2.94e-05	0.000786	CcSEcCtD
Fluorouracil—Somnolence—Gemcitabine—pancreatic cancer	2.93e-05	0.000784	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Irinotecan—pancreatic cancer	2.92e-05	0.000782	CcSEcCtD
Fluorouracil—Alopecia—Docetaxel—pancreatic cancer	2.91e-05	0.000779	CcSEcCtD
Fluorouracil—Pruritus—Sunitinib—pancreatic cancer	2.91e-05	0.000778	CcSEcCtD
Fluorouracil—Pain—Irinotecan—pancreatic cancer	2.89e-05	0.000774	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—pancreatic cancer	2.87e-05	0.000768	CcSEcCtD
Fluorouracil—Erythema—Docetaxel—pancreatic cancer	2.87e-05	0.000767	CcSEcCtD
Fluorouracil—Decreased appetite—Gemcitabine—pancreatic cancer	2.87e-05	0.000767	CcSEcCtD
Fluorouracil—Nausea—Tamoxifen—pancreatic cancer	2.85e-05	0.000762	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	2.85e-05	0.000762	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—pancreatic cancer	2.83e-05	0.000758	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—pancreatic cancer	2.82e-05	0.000756	CcSEcCtD
Fluorouracil—Pain—Gemcitabine—pancreatic cancer	2.82e-05	0.000754	CcSEcCtD
Fluorouracil—Nausea—Erlotinib—pancreatic cancer	2.82e-05	0.000754	CcSEcCtD
Fluorouracil—Diarrhoea—Sunitinib—pancreatic cancer	2.81e-05	0.000752	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—pancreatic cancer	2.79e-05	0.000747	CcSEcCtD
Fluorouracil—Feeling abnormal—Irinotecan—pancreatic cancer	2.79e-05	0.000746	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—pancreatic cancer	2.77e-05	0.000742	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—pancreatic cancer	2.75e-05	0.000735	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—pancreatic cancer	2.72e-05	0.000729	CcSEcCtD
Fluorouracil—Dizziness—Sunitinib—pancreatic cancer	2.72e-05	0.000727	CcSEcCtD
Fluorouracil—Feeling abnormal—Gemcitabine—pancreatic cancer	2.72e-05	0.000727	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—pancreatic cancer	2.7e-05	0.000723	CcSEcCtD
Fluorouracil—Body temperature increased—Irinotecan—pancreatic cancer	2.67e-05	0.000716	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—pancreatic cancer	2.66e-05	0.000711	CcSEcCtD
Fluorouracil—Anaemia—Docetaxel—pancreatic cancer	2.65e-05	0.000709	CcSEcCtD
Fluorouracil—Pancytopenia—Epirubicin—pancreatic cancer	2.63e-05	0.000705	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—pancreatic cancer	2.62e-05	0.000701	CcSEcCtD
Fluorouracil—Vomiting—Sunitinib—pancreatic cancer	2.61e-05	0.000699	CcSEcCtD
Fluorouracil—Body temperature increased—Gemcitabine—pancreatic cancer	2.61e-05	0.000697	CcSEcCtD
Fluorouracil—Rash—Sunitinib—pancreatic cancer	2.59e-05	0.000693	CcSEcCtD
Fluorouracil—Dermatitis—Sunitinib—pancreatic cancer	2.59e-05	0.000693	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—pancreatic cancer	2.58e-05	0.00069	CcSEcCtD
Fluorouracil—Headache—Sunitinib—pancreatic cancer	2.57e-05	0.000689	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—pancreatic cancer	2.57e-05	0.000687	CcSEcCtD
Fluorouracil—Leukopenia—Docetaxel—pancreatic cancer	2.57e-05	0.000687	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—pancreatic cancer	2.54e-05	0.00068	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—pancreatic cancer	2.53e-05	0.000678	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—pancreatic cancer	2.5e-05	0.000669	CcSEcCtD
Fluorouracil—Hypersensitivity—Irinotecan—pancreatic cancer	2.49e-05	0.000667	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—pancreatic cancer	2.49e-05	0.000666	CcSEcCtD
Fluorouracil—Convulsion—Docetaxel—pancreatic cancer	2.48e-05	0.000665	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—pancreatic cancer	2.47e-05	0.000662	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—pancreatic cancer	2.47e-05	0.000662	CcSEcCtD
Fluorouracil—TYMS—Azacitidine—Gemcitabine—pancreatic cancer	2.44e-05	0.026	CbGdCrCtD
Fluorouracil—Chest pain—Docetaxel—pancreatic cancer	2.44e-05	0.000653	CcSEcCtD
Fluorouracil—Myalgia—Docetaxel—pancreatic cancer	2.44e-05	0.000653	CcSEcCtD
Fluorouracil—Nausea—Sunitinib—pancreatic cancer	2.44e-05	0.000653	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—pancreatic cancer	2.44e-05	0.000652	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.42e-05	0.000649	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—pancreatic cancer	2.41e-05	0.000645	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—pancreatic cancer	2.4e-05	0.000644	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—pancreatic cancer	2.4e-05	0.000644	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	2.39e-05	0.000639	CcSEcCtD
Fluorouracil—Confusional state—Docetaxel—pancreatic cancer	2.36e-05	0.000631	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—pancreatic cancer	2.34e-05	0.000627	CcSEcCtD
Fluorouracil—Oedema—Docetaxel—pancreatic cancer	2.34e-05	0.000626	CcSEcCtD
Fluorouracil—Anaphylactic shock—Docetaxel—pancreatic cancer	2.34e-05	0.000626	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—pancreatic cancer	2.33e-05	0.000624	CcSEcCtD
Fluorouracil—Pruritus—Gemcitabine—pancreatic cancer	2.33e-05	0.000624	CcSEcCtD
Fluorouracil—Infection—Docetaxel—pancreatic cancer	2.32e-05	0.000622	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—pancreatic cancer	2.32e-05	0.000621	CcSEcCtD
Fluorouracil—Diarrhoea—Irinotecan—pancreatic cancer	2.32e-05	0.00062	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—pancreatic cancer	2.31e-05	0.000618	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—pancreatic cancer	2.3e-05	0.000616	CcSEcCtD
Fluorouracil—Nervous system disorder—Docetaxel—pancreatic cancer	2.29e-05	0.000614	CcSEcCtD
Fluorouracil—Thrombocytopenia—Docetaxel—pancreatic cancer	2.29e-05	0.000613	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—pancreatic cancer	2.29e-05	0.000613	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—pancreatic cancer	2.29e-05	0.000613	CcSEcCtD
Fluorouracil—Tachycardia—Docetaxel—pancreatic cancer	2.28e-05	0.000611	CcSEcCtD
Fluorouracil—Diarrhoea—Gemcitabine—pancreatic cancer	2.26e-05	0.000604	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.24e-05	0.0006	CcSEcCtD
Fluorouracil—Dizziness—Irinotecan—pancreatic cancer	2.24e-05	0.000599	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—pancreatic cancer	2.23e-05	0.000597	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—pancreatic cancer	2.23e-05	0.000597	CcSEcCtD
Fluorouracil—Anorexia—Docetaxel—pancreatic cancer	2.23e-05	0.000597	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—pancreatic cancer	2.23e-05	0.000596	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—pancreatic cancer	2.22e-05	0.000595	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—pancreatic cancer	2.22e-05	0.000595	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—pancreatic cancer	2.22e-05	0.000594	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—pancreatic cancer	2.21e-05	0.000591	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—pancreatic cancer	2.2e-05	0.00059	CcSEcCtD
Fluorouracil—Hypotension—Docetaxel—pancreatic cancer	2.19e-05	0.000585	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—pancreatic cancer	2.16e-05	0.000578	CcSEcCtD
Fluorouracil—Vomiting—Irinotecan—pancreatic cancer	2.15e-05	0.000576	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—pancreatic cancer	2.15e-05	0.000575	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—pancreatic cancer	2.14e-05	0.000572	CcSEcCtD
Fluorouracil—Rash—Irinotecan—pancreatic cancer	2.13e-05	0.000571	CcSEcCtD
Fluorouracil—Dermatitis—Irinotecan—pancreatic cancer	2.13e-05	0.00057	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.13e-05	0.00057	CcSEcCtD
Fluorouracil—Headache—Irinotecan—pancreatic cancer	2.12e-05	0.000567	CcSEcCtD
Fluorouracil—Insomnia—Docetaxel—pancreatic cancer	2.12e-05	0.000566	CcSEcCtD
Fluorouracil—Paraesthesia—Docetaxel—pancreatic cancer	2.1e-05	0.000562	CcSEcCtD
Fluorouracil—Vomiting—Gemcitabine—pancreatic cancer	2.1e-05	0.000561	CcSEcCtD
Fluorouracil—Dyspnoea—Docetaxel—pancreatic cancer	2.09e-05	0.000558	CcSEcCtD
Fluorouracil—Somnolence—Docetaxel—pancreatic cancer	2.08e-05	0.000557	CcSEcCtD
Fluorouracil—Rash—Gemcitabine—pancreatic cancer	2.08e-05	0.000556	CcSEcCtD
Fluorouracil—Dermatitis—Gemcitabine—pancreatic cancer	2.08e-05	0.000556	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—pancreatic cancer	2.07e-05	0.000553	CcSEcCtD
Fluorouracil—Headache—Gemcitabine—pancreatic cancer	2.06e-05	0.000553	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—pancreatic cancer	2.06e-05	0.000551	CcSEcCtD
Fluorouracil—Dyspepsia—Docetaxel—pancreatic cancer	2.06e-05	0.000551	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—pancreatic cancer	2.05e-05	0.00055	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—pancreatic cancer	2.04e-05	0.000547	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—pancreatic cancer	2.04e-05	0.000546	CcSEcCtD
Fluorouracil—Decreased appetite—Docetaxel—pancreatic cancer	2.03e-05	0.000544	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	2.02e-05	0.00054	CcSEcCtD
Fluorouracil—Nausea—Irinotecan—pancreatic cancer	2.01e-05	0.000538	CcSEcCtD
Fluorouracil—Pain—Docetaxel—pancreatic cancer	2e-05	0.000535	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—pancreatic cancer	1.98e-05	0.000531	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—pancreatic cancer	1.96e-05	0.000525	CcSEcCtD
Fluorouracil—Nausea—Gemcitabine—pancreatic cancer	1.96e-05	0.000524	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—pancreatic cancer	1.93e-05	0.000517	CcSEcCtD
Fluorouracil—Feeling abnormal—Docetaxel—pancreatic cancer	1.93e-05	0.000516	CcSEcCtD
Fluorouracil—Body temperature increased—Docetaxel—pancreatic cancer	1.85e-05	0.000495	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—pancreatic cancer	1.84e-05	0.000491	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—pancreatic cancer	1.82e-05	0.000488	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—pancreatic cancer	1.82e-05	0.000486	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—pancreatic cancer	1.79e-05	0.000479	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—pancreatic cancer	1.79e-05	0.000478	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—pancreatic cancer	1.73e-05	0.000463	CcSEcCtD
Fluorouracil—Hypersensitivity—Docetaxel—pancreatic cancer	1.72e-05	0.000461	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—pancreatic cancer	1.69e-05	0.000451	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—pancreatic cancer	1.67e-05	0.000448	CcSEcCtD
Fluorouracil—Pruritus—Docetaxel—pancreatic cancer	1.65e-05	0.000443	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—pancreatic cancer	1.65e-05	0.000442	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—pancreatic cancer	1.65e-05	0.00044	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—pancreatic cancer	1.65e-05	0.00044	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—pancreatic cancer	1.63e-05	0.000435	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—pancreatic cancer	1.6e-05	0.000428	CcSEcCtD
Fluorouracil—Diarrhoea—Docetaxel—pancreatic cancer	1.6e-05	0.000428	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—pancreatic cancer	1.59e-05	0.000426	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—pancreatic cancer	1.58e-05	0.000422	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—pancreatic cancer	1.58e-05	0.000422	CcSEcCtD
Fluorouracil—Infection—Epirubicin—pancreatic cancer	1.57e-05	0.000419	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—pancreatic cancer	1.55e-05	0.000415	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—pancreatic cancer	1.55e-05	0.000414	CcSEcCtD
Fluorouracil—Dizziness—Docetaxel—pancreatic cancer	1.55e-05	0.000414	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—pancreatic cancer	1.54e-05	0.000413	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—pancreatic cancer	1.54e-05	0.000412	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—pancreatic cancer	1.52e-05	0.000408	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—pancreatic cancer	1.52e-05	0.000408	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—pancreatic cancer	1.5e-05	0.000403	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—pancreatic cancer	1.5e-05	0.000402	CcSEcCtD
Fluorouracil—Vomiting—Docetaxel—pancreatic cancer	1.49e-05	0.000398	CcSEcCtD
Fluorouracil—Rash—Docetaxel—pancreatic cancer	1.47e-05	0.000395	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—pancreatic cancer	1.47e-05	0.000395	CcSEcCtD
Fluorouracil—Dermatitis—Docetaxel—pancreatic cancer	1.47e-05	0.000394	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—pancreatic cancer	1.47e-05	0.000394	CcSEcCtD
Fluorouracil—Headache—Docetaxel—pancreatic cancer	1.47e-05	0.000392	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.46e-05	0.000391	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—pancreatic cancer	1.46e-05	0.000391	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—pancreatic cancer	1.45e-05	0.000388	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.44e-05	0.000385	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—pancreatic cancer	1.43e-05	0.000383	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.43e-05	0.000383	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—pancreatic cancer	1.43e-05	0.000382	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—pancreatic cancer	1.42e-05	0.000381	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—pancreatic cancer	1.42e-05	0.000379	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—pancreatic cancer	1.41e-05	0.000376	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—pancreatic cancer	1.4e-05	0.000375	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—pancreatic cancer	1.39e-05	0.000372	CcSEcCtD
Fluorouracil—Nausea—Docetaxel—pancreatic cancer	1.39e-05	0.000372	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—pancreatic cancer	1.39e-05	0.000372	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—pancreatic cancer	1.37e-05	0.000367	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—pancreatic cancer	1.36e-05	0.000365	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.36e-05	0.000365	CcSEcCtD
Fluorouracil—Pain—Epirubicin—pancreatic cancer	1.35e-05	0.000361	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.33e-05	0.000356	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—pancreatic cancer	1.32e-05	0.000353	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—pancreatic cancer	1.31e-05	0.000351	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—pancreatic cancer	1.3e-05	0.000348	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—pancreatic cancer	1.3e-05	0.000348	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—pancreatic cancer	1.3e-05	0.000347	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—pancreatic cancer	1.29e-05	0.000344	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—pancreatic cancer	1.27e-05	0.00034	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.26e-05	0.000337	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—pancreatic cancer	1.25e-05	0.000335	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—pancreatic cancer	1.25e-05	0.000334	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—pancreatic cancer	1.25e-05	0.000334	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—pancreatic cancer	1.2e-05	0.000322	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—pancreatic cancer	1.16e-05	0.000311	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—pancreatic cancer	1.16e-05	0.00031	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—pancreatic cancer	1.15e-05	0.000309	CcSEcCtD
Fluorouracil—Pruritus—Epirubicin—pancreatic cancer	1.12e-05	0.000299	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—pancreatic cancer	1.08e-05	0.000289	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—pancreatic cancer	1.08e-05	0.000288	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—pancreatic cancer	1.04e-05	0.000279	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—pancreatic cancer	1.03e-05	0.000276	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—pancreatic cancer	1e-05	0.000268	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—pancreatic cancer	9.99e-06	0.000267	CcSEcCtD
Fluorouracil—Rash—Epirubicin—pancreatic cancer	9.95e-06	0.000266	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—pancreatic cancer	9.94e-06	0.000266	CcSEcCtD
Fluorouracil—Headache—Epirubicin—pancreatic cancer	9.88e-06	0.000265	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—pancreatic cancer	9.65e-06	0.000258	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—pancreatic cancer	9.37e-06	0.000251	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—pancreatic cancer	9.28e-06	0.000248	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—pancreatic cancer	9.2e-06	0.000246	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—pancreatic cancer	9.2e-06	0.000246	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—pancreatic cancer	9.15e-06	0.000245	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—pancreatic cancer	8.67e-06	0.000232	CcSEcCtD
Fluorouracil—ALB—Metabolism—PRSS1—pancreatic cancer	2.65e-06	6.87e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GCG—pancreatic cancer	2.64e-06	6.84e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GLP1R—pancreatic cancer	2.63e-06	6.8e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IFNA2—pancreatic cancer	2.61e-06	6.75e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NOTCH1—pancreatic cancer	2.6e-06	6.72e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—DPYD—pancreatic cancer	2.58e-06	6.69e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CD—pancreatic cancer	2.56e-06	6.64e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGF—pancreatic cancer	2.51e-06	6.5e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—STK11—pancreatic cancer	2.48e-06	6.43e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.45e-06	6.35e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTEN—pancreatic cancer	2.45e-06	6.35e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	2.45e-06	6.33e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CG—pancreatic cancer	2.44e-06	6.33e-05	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PIK3CA—pancreatic cancer	2.43e-06	6.29e-05	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PIK3CA—pancreatic cancer	2.43e-06	6.29e-05	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—pancreatic cancer	2.43e-06	6.28e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GLP1R—pancreatic cancer	2.39e-06	6.18e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PPARG—pancreatic cancer	2.36e-06	6.11e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—APOE—pancreatic cancer	2.36e-06	6.1e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—DPYD—pancreatic cancer	2.35e-06	6.08e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.33e-06	6.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ARG2—pancreatic cancer	2.31e-06	5.99e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ARG2—pancreatic cancer	2.3e-06	5.96e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CB—pancreatic cancer	2.23e-06	5.79e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SRC—pancreatic cancer	2.23e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CD—pancreatic cancer	2.23e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	2.23e-06	5.77e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—pancreatic cancer	2.21e-06	5.74e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—pancreatic cancer	2.17e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.17e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—pancreatic cancer	2.15e-06	5.56e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CD—pancreatic cancer	2.15e-06	5.56e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TYMS—pancreatic cancer	2.14e-06	5.53e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CG—pancreatic cancer	2.13e-06	5.51e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—APOE—pancreatic cancer	2.1e-06	5.44e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PPARG—pancreatic cancer	2.05e-06	5.32e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.02e-06	5.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMP—pancreatic cancer	2.01e-06	5.21e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—pancreatic cancer	2e-06	5.17e-05	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—pancreatic cancer	1.99e-06	5.16e-05	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—pancreatic cancer	1.98e-06	5.14e-05	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—pancreatic cancer	1.98e-06	5.14e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—pancreatic cancer	1.98e-06	5.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.96e-06	5.08e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CB—pancreatic cancer	1.95e-06	5.04e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTEN—pancreatic cancer	1.93e-06	5e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—pancreatic cancer	1.93e-06	4.99e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.91e-06	4.94e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CD44—pancreatic cancer	1.9e-06	4.92e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CG—pancreatic cancer	1.89e-06	4.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.88e-06	4.88e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CB—pancreatic cancer	1.87e-06	4.85e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CD—pancreatic cancer	1.87e-06	4.84e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.86e-06	4.81e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—pancreatic cancer	1.85e-06	4.8e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLAU—pancreatic cancer	1.85e-06	4.79e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—pancreatic cancer	1.85e-06	4.79e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PPARG—pancreatic cancer	1.83e-06	4.73e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GCG—pancreatic cancer	1.82e-06	4.72e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SRC—pancreatic cancer	1.79e-06	4.64e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.75e-06	4.54e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—APOE—pancreatic cancer	1.74e-06	4.5e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	4.48e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—pancreatic cancer	1.73e-06	4.47e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CD44—pancreatic cancer	1.73e-06	4.47e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—pancreatic cancer	1.72e-06	4.47e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—pancreatic cancer	1.72e-06	4.46e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—STK11—pancreatic cancer	1.71e-06	4.43e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	1.7e-06	4.4e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTEN—pancreatic cancer	1.68e-06	4.35e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.67e-06	4.32e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CD—pancreatic cancer	1.66e-06	4.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.66e-06	4.3e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GCG—pancreatic cancer	1.65e-06	4.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.65e-06	4.26e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.65e-06	4.26e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.64e-06	4.26e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—pancreatic cancer	1.64e-06	4.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.63e-06	4.22e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CB—pancreatic cancer	1.63e-06	4.22e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EGF—pancreatic cancer	1.63e-06	4.21e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GLP1R—pancreatic cancer	1.62e-06	4.2e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTEN—pancreatic cancer	1.62e-06	4.19e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—pancreatic cancer	1.61e-06	4.18e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.61e-06	4.17e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—pancreatic cancer	1.6e-06	4.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.6e-06	4.15e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—pancreatic cancer	1.6e-06	4.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—DPYD—pancreatic cancer	1.59e-06	4.13e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—pancreatic cancer	1.57e-06	4.07e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—pancreatic cancer	1.57e-06	4.07e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CG—pancreatic cancer	1.57e-06	4.06e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SRC—pancreatic cancer	1.56e-06	4.04e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—STK11—pancreatic cancer	1.56e-06	4.03e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.52e-06	3.94e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC2A2—pancreatic cancer	1.51e-06	3.92e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—pancreatic cancer	1.51e-06	3.92e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.51e-06	3.9e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—pancreatic cancer	1.5e-06	3.89e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—pancreatic cancer	1.5e-06	3.88e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.5e-06	3.88e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.49e-06	3.86e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—pancreatic cancer	1.48e-06	3.84e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TYMS—pancreatic cancer	1.47e-06	3.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.45e-06	3.76e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CB—pancreatic cancer	1.45e-06	3.76e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.45e-06	3.75e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.45e-06	3.74e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—pancreatic cancer	1.44e-06	3.72e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—pancreatic cancer	1.41e-06	3.66e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—pancreatic cancer	1.41e-06	3.65e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.41e-06	3.64e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—pancreatic cancer	1.4e-06	3.62e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—pancreatic cancer	1.39e-06	3.61e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—pancreatic cancer	1.39e-06	3.59e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CD—pancreatic cancer	1.38e-06	3.57e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—pancreatic cancer	1.37e-06	3.54e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—pancreatic cancer	1.36e-06	3.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.36e-06	3.52e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TYMS—pancreatic cancer	1.34e-06	3.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.33e-06	3.44e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.32e-06	3.43e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.32e-06	3.41e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.31e-06	3.38e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—pancreatic cancer	1.29e-06	3.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.26e-06	3.26e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—pancreatic cancer	1.26e-06	3.26e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—pancreatic cancer	1.25e-06	3.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.24e-06	3.21e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.23e-06	3.17e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.22e-06	3.15e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—pancreatic cancer	1.2e-06	3.11e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOE—pancreatic cancer	1.2e-06	3.1e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—pancreatic cancer	1.19e-06	3.08e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—pancreatic cancer	1.19e-06	3.07e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.18e-06	3.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CD44—pancreatic cancer	1.18e-06	3.05e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CD44—pancreatic cancer	1.17e-06	3.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.16e-06	3.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.15e-06	2.99e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.15e-06	2.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.14e-06	2.96e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—pancreatic cancer	1.14e-06	2.95e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.14e-06	2.94e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.13e-06	2.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GCG—pancreatic cancer	1.13e-06	2.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GCG—pancreatic cancer	1.12e-06	2.91e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.12e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—pancreatic cancer	1.11e-06	2.88e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—pancreatic cancer	1.1e-06	2.84e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOE—pancreatic cancer	1.09e-06	2.82e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.08e-06	2.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.08e-06	2.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—STK11—pancreatic cancer	1.06e-06	2.75e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.06e-06	2.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—STK11—pancreatic cancer	1.06e-06	2.74e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.05e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—pancreatic cancer	1.04e-06	2.7e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—pancreatic cancer	1.04e-06	2.69e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.01e-06	2.62e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—pancreatic cancer	1.01e-06	2.62e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.97e-07	2.58e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—pancreatic cancer	9.93e-07	2.57e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.92e-07	2.57e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—pancreatic cancer	9.84e-07	2.55e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	9.82e-07	2.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—pancreatic cancer	9.72e-07	2.52e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—pancreatic cancer	9.69e-07	2.51e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CD44—pancreatic cancer	9.59e-07	2.48e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—pancreatic cancer	9.5e-07	2.46e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—pancreatic cancer	9.48e-07	2.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.39e-07	2.43e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—pancreatic cancer	9.32e-07	2.41e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.31e-07	2.41e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.21e-07	2.38e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GCG—pancreatic cancer	9.2e-07	2.38e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMS—pancreatic cancer	9.14e-07	2.37e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMS—pancreatic cancer	9.09e-07	2.35e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—pancreatic cancer	9.03e-07	2.34e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—pancreatic cancer	8.85e-07	2.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—STK11—pancreatic cancer	8.65e-07	2.24e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	8.63e-07	2.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—pancreatic cancer	8.36e-07	2.17e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—pancreatic cancer	8.28e-07	2.15e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—pancreatic cancer	8.21e-07	2.13e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CD44—pancreatic cancer	8.2e-07	2.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.12e-07	2.1e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—pancreatic cancer	8.11e-07	2.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.03e-07	2.08e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.95e-07	2.06e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GCG—pancreatic cancer	7.86e-07	2.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—pancreatic cancer	7.68e-07	1.99e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	7.52e-07	1.95e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—pancreatic cancer	7.46e-07	1.93e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMS—pancreatic cancer	7.44e-07	1.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—pancreatic cancer	7.43e-07	1.93e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOE—pancreatic cancer	7.43e-07	1.92e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOE—pancreatic cancer	7.39e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—STK11—pancreatic cancer	7.39e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—pancreatic cancer	7.32e-07	1.9e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—pancreatic cancer	7.23e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—pancreatic cancer	7.16e-07	1.85e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—pancreatic cancer	7.11e-07	1.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.04e-07	1.82e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7e-07	1.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.94e-07	1.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	6.71e-07	1.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—pancreatic cancer	6.67e-07	1.73e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—pancreatic cancer	6.5e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—pancreatic cancer	6.47e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—pancreatic cancer	6.44e-07	1.67e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.36e-07	1.65e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—pancreatic cancer	6.28e-07	1.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOE—pancreatic cancer	6.05e-07	1.57e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—pancreatic cancer	5.98e-07	1.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	5.9e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—pancreatic cancer	5.86e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.73e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.46e-07	1.41e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—pancreatic cancer	5.27e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOE—pancreatic cancer	5.17e-07	1.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	5.14e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—pancreatic cancer	5.11e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—pancreatic cancer	5.09e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—pancreatic cancer	5.06e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.05e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.89e-07	1.27e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	4.8e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.67e-07	1.21e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	4.59e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.5e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—pancreatic cancer	4.44e-07	1.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—pancreatic cancer	4.42e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.18e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.14e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—pancreatic cancer	4.12e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.1e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—pancreatic cancer	3.75e-07	9.7e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.61e-07	9.36e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.57e-07	9.26e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.54e-07	9.17e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.13e-07	8.11e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—pancreatic cancer	3.12e-07	8.07e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.09e-07	8e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.56e-07	6.63e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.55e-07	6.6e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—pancreatic cancer	2.55e-07	6.59e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.18e-07	5.64e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.08e-07	5.4e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.78e-07	4.61e-06	CbGpPWpGaD
